MissionIR Articles

Industrial hemp market estimated at $4.7 billion in 2019, expected to grow 15.8% by 2027 Company plans to capitalize on convergence of CBD within nutrition, health products market CIIX uniquely positioned to target China’s consumer…

In recent MoneyTV interview, CIIX CEO reveals new hemp-based health and wellness, financial products New products leverage current surge in demand for personal protection supplies as well as increased retail investors’ activity CIIX already launching…

CIIX concentrating on multi-pronged growth strategy The company operates a top financial-information website, developing CBD initiatives CIIX offers investors unique, contemporary ROI opportunities A fintech enterprise, ChineseInvestors.com Inc. (OTCQB: CIIX) is focusing on its original…

CIIX CEO discusses numerous health benefits of company’s CBD-based products during MoneyTV interview Company has engaged in international campaign in China, the U.S. to raise awareness of CBD oil’s myriad benefits CIIX is a compelling…

CEO announces that company will sponsor infomercials touting benefits of CBD oil sold through CBD Biotech Co. subsidiary CBD-oil awareness campaign consists of China AM radio infomercial, WeChat group infomercial and New York radio infomercial…

CBD Biotech seizing immense opportunities in untapped CBD Chinese market CIIX operates both online, physical CBD stores in addition to developing first Chinese, CBD-based social media app CIIX’s hemp-based products fully legal in China with…

CIIX leverages its robust financial expertise to become leader in nascent Chinese CBD market CEO discusses potential health benefits of CBD-based products as China – and world – faces spread of coronavirus Wang emphasizes tremendous…

CIIX subsidiary working to expand customer base with new hemp-based CBD products in 2020 CEO focused on profits in 2020; plans to create strategic B2B, B2C divisions CBD Biotech unaffected by changing CBD-product regulations due…

CIIX CEO said company will employ social media as it markets new CBD products starting March 2020 CIIX subsidiary CBD Biotech Co. focused on driving growth, building online sales to younger demographics in China Goals…

Maximizing profit by creating, leveraging products with 10-to-20x profitability margins Investors encouraged to review CBD Biotech’s impressive product line, strategic plan for revenue increase. Driving growth in new year with growing demand for CBD products…

ChineseInvestors.com has become top financial-information website The company is also advancing its cannabidiol program CIIX offers investors multiple revenue streams, healthy return potential Based in San Gabriel, California, ChineseInvestors.com Inc. (OTCQB: CIIX) offers a proprietary…

CIIX CEO speaks to attaining profitability in 2020 as company grows revenue Subsidiary CBD Biotech and CBD cosmetics instrumental in driving CIIX’s growth CIIX leadership focusing on cost cutting, maintaining profitability, and increased revenue with…

Featured on SmallCapVoice.com interview, Warren Wang outlines plans for CIIX subsidiary, CBD Biotech Inc. CBD Biotech one of few players in China’s fast-growing CBD market Company to focus on hemp/CBD-infused cosmetic products ChineseInvestors.com Inc. (OTCQB:…

ChineseInvestors.com is foremost financial information website for Chinese-speaking investors in U.S. and China CIIX subsidiary was featured in a recent Wall Street Journal report on China’s growing cannabis industry ChineseInvestors.com has highly diversified revenue streams…

CIIX CEO Warren Wang and CBD Biotech executives attended 2019 China Industrial Cannabis CBD Industry International Conference At well over one billion people, China’s cannabis industry market potential is four times the size of America’s…

Wall Street Journal analyzes China’s potential as a cannabis global superpower CEO of CIIX subsidiary discusses company’s role as CBD legal marketer in China, United States CIIX CEO says company is a first mover in…

CIIX anticipates launch of hemp-infused wrinkle cream in China Through subsidiary CBD Biotech, CIIX will focus hemp and CBD products on the blooming Chinese market The company noted impressive sales, revenue growth for Q1 2020,…

CIIX will diversify revenue streams to investor relations, marketing/sales of hemp-infused/CBD products in China and the United States Company plans launch of hemp-infused wrinkle cream in China, entering potential market of nearly 1.4 billion people…

CIIX has carved out unique niche in Chinese-speaking markets, is applying similar business model to rapidly growing CBD industry Focused on China’s emerging industrial hemp and CBD market, which is predicted to reach over $20…

In MoneyTV interview, CEO Warren Wang notes company’s focus on increasing core investor relations and public relations businesses Investor relations, public relations segment a significant revenue driver for CIIX CIIX 10-K SEC filing reports revenue…